No definition available.
Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)
C3_MARGINAL_ZONE_LYMPHOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
532 |
4. Check minimum number of eventsNone |
532 |
5. Include endpointsNone |
532 |
6. Filter based on genotype QC (FinnGen only) |
532 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 532 | 263 | 269 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.12 |
| Median age at first event (years) | 64.89 | 63.61 | 66.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 265
- Matched controls
- 2650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
285.9
220
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
578.5
113.7
105
*
XW000
NOMESCO Finland
Bone marrow biopsy
55.1
89.1
105
31
JN4BD
NOMESCO Finland
Extensive body CT
26.5
82.5
120
80
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
904.7
72.7
68
*
WF002
NOMESCO Finland
Radical radiotherapy
308.9
71.0
69
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
608.6
52.3
50
*
A03FA01
ATC
metoclopramide; systemic, rectal
10.4
49.5
110
169
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
44.0
41
*
JN4AD
NOMESCO Finland
Body CT examination
23.4
42.7
62
34
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
48.1
42.5
51
13
A04AA02
ATC
granisetron; systemic, transdermal
+∞
41.8
39
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
32.0
39.4
52
20
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
38.5
36
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
38.5
36
*
JN6AD
NOMESCO Finland
CT of torso and neck
82.6
38.2
42
6
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
151.6
37.8
39
*
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
37.4
35
*
H02AB02
ATC
dexamethasone; systemic
56.6
36.9
43
9
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
410.0
36.9
36
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.8
36.6
137
412
L03AA13
ATC
pegfilgrastim; parenteral
+∞
35.2
33
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
34.1
32
*
L03AA02
ATC
filgrastim; parenteral
+∞
34.1
32
*
XX3DW
NOMESCO Finland
Time consuming IT work
13.3
33.1
60
57
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
187.5
32.5
33
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
30.8
29
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
29.7
28
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
12.7
28.9
53
51
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
28.7
27
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
+∞
28.7
27
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
25.4
24
*
A04AA01
ATC
ondansetron; systemic, rectal
17.2
25.2
40
27
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
23.3
22
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
22.2
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
22.2
21
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
21.1
20
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
119.4
20.9
22
*
M04AA01
ATC
allopurinol; systemic
4.9
20.2
74
194
ZX120
NOMESCO Finland
Intravenous
6.7
20.2
54
97
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
20.0
19
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
20.0
19
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
20.2
19.6
29
16
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
19.0
18
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
19.0
18
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
41.7
18.9
23
6
WW500
NOMESCO Finland
Blood transfusion
15.9
18.6
30
21
1XC02
NOMESCO Finland
NA
47.7
18.5
22
5
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.5
18.0
40
54
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
17.9
17
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.9
17
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
192.2
17.7
18
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
67.9
17.0
19
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
67.9
17.0
19
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
16.8
16
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.8
16
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
16.8
16
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
15.8
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.8
15
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
15.8
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
169.5
15.6
16
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
15.2
114
523
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
14.7
14
*
130
Kela drug reimbursment
Malignant tumour
+∞
14.7
14
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.7
14
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
14.7
14
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.8
14.6
51
124
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
38.4
14.6
18
5
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.7
14.4
52
131
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
14.3
90
363
Z51.5
ICD-10 Finland
Palliative care
12.4
14.1
25
22
ZX112
NOMESCO Finland
Subcutaneous
32.0
14.1
18
6
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
79.3
13.7
15
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
79.3
13.7
15
*
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
13.7
13
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
11.9
13.3
24
22
WZC30
NOMESCO Finland
Teaching
4.5
13.2
49
127
R50.9
ICD-10 Finland
Fever, unspecified
4.0
13.0
56
167
CFA20
NOMESCO Finland
Biopsy of conjunctiva
52.7
13.0
15
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
12.9
58
179
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.6
12
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
136.1
12.5
13
*
A02BC02
ATC
pantoprazole; systemic
2.7
12.4
195
1342
JN4CD
NOMESCO Finland
Very extensive body CT
13.3
12.3
21
17
H02AB06
ATC
prednisolone; systemic
2.6
12.1
149
885
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
12.1
142
824
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
11.5
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
11.5
11
*
HA1AA
NOMESCO Finland
X-ray mammography
8.4
11.1
24
31
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
14.7
11.1
18
13
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
22.6
10.8
15
7
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.4
10.8
28
48
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.8
10.7
21
23
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
10.5
119
661
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
114.3
10.5
11
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
16.9
10.5
16
10
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
10.5
10
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
10.5
10
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.0
9.5
16
13
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
103.5
9.5
10
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
9.0
35
95
N02AA05
ATC
oxycodone; systemic
3.3
8.7
45
154
WX402
NOMESCO Finland
General anaesthesia
3.2
8.7
48
171
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
92.8
8.5
9
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
92.8
8.5
9
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
92.8
8.5
9
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
92.8
8.5
9
*
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
92.8
8.5
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
8.4
66
295
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.9
8.4
16
17
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
8.4
8
*
L01AA02
ATC
chlorambucil; oral
+∞
8.4
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.4
8
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
8.4
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.4
8
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
8.4
8
*
1AA09
NOMESCO Finland
NA
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
8.4
8
*
H02AB07
ATC
prednisone; oral
2.9
8.3
52
203
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
8.3
57
236
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
8.2
40
131
GD1AD
NOMESCO Finland
Thorax CT examination
5.3
8.1
24
49
WX002
NOMESCO Finland
Sedation and analgesia
2.5
7.8
67
313
CBA10
NOMESCO Finland
Biopsy of eyelid
15.6
7.8
12
8
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
15.6
7.8
12
8
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.2
7.8
29
76
ZXA05
NOMESCO Finland
Left side
2.3
7.7
81
422
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.8
7.4
14
15
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
7.3
7
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
7.3
7
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
7.3
7
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
30.9
7.2
9
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
30.9
7.2
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.5
7.1
12
10
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.7
6.9
13
14
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.2
6.8
20
41
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
41.1
6.8
8
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
41.1
6.8
8
*
WX110
NOMESCO Finland
Local anesthesy
2.0
6.7
173
1287
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
71.4
6.5
7
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
71.4
6.5
7
*
J05AB11
ATC
valaciclovir; oral
2.8
6.4
41
162
B01AB05
ATC
enoxaparin; parenteral
2.1
6.4
86
492
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
18.5
6.3
9
5
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
+∞
6.3
6
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
27.4
6.3
8
*
ZX108
NOMESCO Finland
Inhalation
27.4
6.3
8
*
UJF32
NOMESCO Finland
Coloscopy
2.1
6.3
77
425
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
8.0
6.2
13
17
B01AB10
ATC
tinzaparin; parenteral
4.5
6.1
20
47
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
6.1
28
89
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
376
404
29.33
307.65
7.1
2.9
234.3
238.9
u/l
0.30
370
381
216
289
11.90
165.31
4.0
2.2
9.2
10.8
g/l
3.49
207
266
116
55
26.69
159.66
1.9
1.8
—
—
—
0
0
80
19
49.38
135.68
2.6
1.9
14.8
11.3
%
—
29
9
74
17
50.40
126.26
2.7
2.1
—
—
—
0
0
170
237
10.07
123.28
3.1
1.3
2.8
1.1
g/l
3.07
163
216
347
1186
6.54
101.07
4.1
2.4
884.3
7237.2
umol/l
3.68
339
1009
86
62
16.35
95.96
5.8
5.6
590.6
132.1
iu/ml
—
18
9
435
1905
8.04
93.43
11.9
5.5
28.6
27.2
%
1.26
424
1765
78
49
18.48
93.41
2.4
2.4
11015.0
567.1
u/ml
—
5
8
429
1891
7.55
90.25
11.0
5.3
55.7
57.6
%
2.03
416
1760
442
2069
7.72
84.72
13.4
3.7
10.7
11.7
umol/l
1.90
435
1937
459
2238
8.66
83.62
22.0
6.2
3.4
4.3
e9/l
19.77
432
1959
52
16
35.91
81.67
4.1
1.7
553.5
1279.7
e6/l
—
27
6
161
354
6.09
73.66
2.6
1.6
66.0
67.8
g/l
1.59
150
316
50
21
26.18
70.76
4.4
2.4
29.6
46.7
%
—
26
8
389
1812
5.27
69.27
7.5
3.5
35.1
35.5
g/l
0.86
374
1676
92
133
8.15
62.62
2.1
1.4
23.1
31.5
mg/l
1.71
82
108
92
133
8.15
62.62
2.2
1.4
51.0
42.7
mg/l
0.38
80
109
197
599
4.63
60.19
5.9
2.6
0.8
0.8
mmol/l
1.36
191
549
78
99
9.06
59.04
1.9
1.5
—
—
—
0
0
402
2133
4.62
54.79
9.8
5.4
1.2
1.2
mmol/l
0.84
339
1815
87
140
7.23
53.53
2.7
1.4
2.0
0.5
g/l
2.02
78
120
96
172
6.59
53.28
2.6
1.4
7.0
7.8
g/l
2.79
76
123
96
172
6.59
53.28
2.6
1.4
—
—
—
0
0
57
56
11.28
51.95
1.5
1.4
107.2
109.2
u/ml
—
20
6
92
162
6.66
51.89
2.7
1.4
3.1
3.1
g/l
0.02
73
122
94
172
6.42
51.00
2.6
1.4
3.6
3.9
g/l
0.48
71
120
88
160
6.39
47.94
2.7
1.4
10.3
10.5
g/l
0.07
76
131
366
1951
3.81
46.28
8.3
5.0
1.2
1.2
mmol/l
1.37
358
1730
52
56
10.18
44.31
2.9
2.1
33.9
33.2
pg
0.42
52
56
45
41
11.90
42.96
5.7
3.3
1.0
1.1
%
0.05
37
32
60
81
8.22
42.85
2.1
1.5
—
—
—
0
0
288
1379
3.37
41.98
6.0
2.0
2.4
2.4
mmol/l
0.10
269
1131
52
62
9.19
41.01
1.5
1.2
—
—
—
0
0
61
89
7.61
40.71
2.0
1.5
—
—
—
0
0
50
60
9.09
39.20
2.1
1.6
—
—
—
0
0
42
5
91.09
38.40
2.6
1.6
—
—
—
0
0
477
3245
5.55
38.23
18.6
5.3
80.5
75.7
u/l
2.20
471
2969
32
0
+∞
33.70
1.1
0.0
—
—
—
0
0
68
138
5.50
32.63
2.3
3.3
—
—
—
0
0
45
62
7.84
31.42
1.6
1.4
—
—
—
0
0
169
689
3.13
30.56
2.8
1.8
—
—
—
0
0
32
29
11.68
30.49
7.0
3.3
48.7
47.6
%
0.06
21
21
462
3274
4.12
30.05
7.9
4.2
17.4
12.5
mm/h
5.92
448
2985
317
1842
2.78
29.03
6.1
3.5
—
—
—
0
0
86
239
4.10
27.95
2.3
1.4
3.0
4.0
ug/l
0.34
61
186
35
46
8.07
25.35
1.7
1.5
—
—
—
0
0
29
31
9.84
24.62
1.4
1.7
—
—
—
0
0
128
498
3.07
24.54
2.5
1.8
—
—
—
0
0
31
37
8.83
24.23
2.3
1.4
—
—
—
0
0
38
58
6.98
24.15
1.2
1.2
268.0
286.7
u/ml
0.11
23
34
22
16
14.30
23.77
3.5
1.5
—
—
—
0
0
29
33
9.24
23.50
2.1
1.5
—
—
—
0
0
126
497
3.01
23.49
2.5
1.8
—
—
—
0
0
35
51
7.28
23.18
1.7
1.4
—
—
—
0
0
34
48
7.50
23.15
1.7
1.4
—
—
—
0
0
22
17
13.46
22.97
2.3
1.1
—
—
—
0
0
22
17
13.46
22.97
2.3
1.1
—
—
—
0
0
22
17
13.46
22.97
2.3
1.1
—
—
—
0
0
22
17
13.46
22.97
2.3
1.1
—
—
—
0
0
27
6
47.24
22.57
4.8
1.2
—
—
—
0
0
68
188
4.00
22.09
4.2
1.7
1.4
1.5
g/l
0.16
57
166
146
643
2.75
22.04
2.8
1.8
29.9
29.5
s
0.34
139
623
38
64
6.32
21.98
1.1
1.1
—
—
—
0
0
42
79
5.69
21.72
1.5
1.3
—
—
—
0
0
135
580
2.78
21.31
2.4
2.3
2.2
2.3
g/l
0.92
125
537
185
932
2.51
21.09
3.7
2.0
—
—
—
0
0
128
543
2.79
20.64
2.5
2.4
23.4
23.7
%
0.04
111
463
35
61
6.07
19.55
1.3
1.3
144.2
273.0
miu/ml
—
8
23
30
45
7.01
19.32
1.9
1.7
—
—
—
0
0
137
636
2.55
18.23
2.6
2.3
13.1
13.4
umol/l
0.13
129
583
365
2574
2.33
18.06
5.7
4.4
6.6
6.8
mmol/l
1.66
355
2400
24
32
7.81
17.09
2.2
1.1
—
—
—
0
0
24
32
7.81
17.09
2.2
1.1
—
—
—
0
0
24
32
7.81
17.09
2.2
1.1
—
—
—
0
0
103
428
2.74
17.04
3.9
2.3
5.8
6.9
umol/l
0.82
95
372
21
9
24.22
15.21
2.2
1.1
—
—
—
0
0
21
9
24.22
15.21
2.2
1.1
—
—
—
0
0
21
9
24.22
15.21
2.2
1.2
—
—
—
0
0
84
333
2.81
15.11
1.8
1.8
0.2
0.2
g/l
0.97
74
294
29
55
5.52
14.82
1.9
1.5
—
—
—
0
0
196
1149
2.12
14.60
3.7
3.0
0.3
0.4
e6/l
1.23
144
853
19
23
8.53
14.59
1.6
1.6
—
—
—
0
0
19
23
8.53
14.59
1.6
1.6
—
—
—
0
0
188
1100
2.10
13.96
2.4
2.2
3.1
3.0
mg/l
0.22
169
927
17
19
9.21
13.84
2.3
1.7
—
—
—
0
0
17
19
9.21
13.84
2.3
1.7
—
—
—
0
0
71
270
2.88
13.76
2.7
1.5
—
—
—
0
0
127
652
2.25
13.04
3.0
2.8
2.1
2.1
e6/l
0.02
68
344
36
93
4.08
12.74
1.9
1.7
44.3
142.0
u/ml
0.54
31
72
17
22
7.95
12.35
1.7
1.3
—
—
—
0
0
18
25
7.42
12.34
1.2
1.2
—
—
—
0
0
262
1784
1.92
12.22
2.6
2.2
80.5
78.3
nmol/l
0.51
245
1541
31
75
4.33
11.95
4.9
3.3
56.4
58.9
%
0.36
31
75
365
2788
1.98
11.91
5.6
4.3
2356.1
3471.7
e6/l
—
7
41
20
33
6.26
11.74
2.1
1.6
—
—
—
0
0
230
1518
1.91
11.63
4.2
3.0
—
—
—
0
0
17
25
6.99
11.08
2.3
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
118
3.49
11.03
2.7
3.0
0.3
0.4
u/ml
0.85
26
70
92
442
2.31
10.93
4.4
3.2
—
—
—
0
0
35
100
3.68
10.78
1.1
1.4
—
—
—
0
0
14
17
8.43
10.66
2.1
1.1
—
—
—
0
0
14
17
8.43
10.66
2.1
1.1
—
—
—
0
0
152
895
1.98
10.63
3.4
4.1
269.2
364.0
ng/l
0.19
124
731
129
717
2.05
10.59
2.8
2.6
0.9
1.1
e6/l
0.30
68
408
251
1740
1.84
10.59
3.4
2.6
283.4
131.3
ug/l
3.81
235
1572
12
12
10.21
10.47
1.3
1.0
—
—
—
0
0
29
74
4.09
10.44
4.4
3.0
3.2
4.5
e9/l
3.75
29
74
15
8
19.24
10.31
3.6
2.0
—
—
—
0
0
15
22
6.99
9.78
1.9
1.0
214.1
354.3
u/l
0.65
15
22
75
350
2.33
9.48
2.2
2.1
29.4
45.9
u/l
0.68
61
289
14
8
17.93
9.44
1.4
1.4
—
—
—
0
0
15
24
6.40
9.03
2.1
2.8
3407.3
1372.7
u/ml
0.81
15
24
12
5
24.48
8.94
1.2
1.2
—
—
—
0
0
12
15
8.16
8.89
2.2
1.1
—
—
—
0
0
12
15
8.16
8.89
2.2
1.1
—
—
—
0
0
36
120
3.15
8.75
1.8
1.2
—
—
—
0
0
58
257
2.41
8.22
2.0
1.7
—
—
—
0
0
190
1284
1.75
8.21
6.4
2.6
28.3
34.9
u/l
2.24
182
1218
481
4262
2.34
7.98
34.7
13.0
21.7
23.7
mg/l
0.62
453
3307
56
251
2.38
7.74
2.0
1.5
—
—
—
0
0
21
53
4.08
7.68
1.1
1.1
—
—
—
0
0
31
108
2.99
7.02
1.6
1.7
—
—
—
0
0
142
919
1.74
6.98
1.8
1.6
1.6
1.2
mg/l
1.03
114
705
18
44
4.20
6.86
3.5
1.1
—
—
—
0
0
40
162
2.59
6.85
3.1
1.6
—
—
—
0
0
18
45
4.11
6.67
3.5
1.1
—
—
—
0
0
18
45
4.11
6.67
3.5
1.1
—
—
—
0
0
34
130
2.73
6.52
1.4
1.2
2.2
3.1
u/ml
0.47
11
18
18
46
4.02
6.49
3.5
1.1
—
—
—
0
0
18
46
4.02
6.49
3.5
1.1
—
—
—
0
0
18
46
4.02
6.49
3.5
1.1
—
—
—
0
0
34
133
2.66
6.25
1.4
1.2
1.8
8.2
u/ml
0.90
14
21
35
139
2.62
6.24
1.4
1.2
46.3
21.8
u/ml
—
9
7
14
30
4.77
6.24
1.6
1.1
13766.7
21613.7
e6/l
—
6
16
11
19
5.89
6.13
1.3
2.1
1.9
3.3
nmol/l
0.87
11
19
190
1375
1.59
5.91
2.8
2.1
56.4
57.0
u/l
0.08
174
1254
49
234
2.21
5.86
4.6
7.9
25.5
25.1
mmol/l
0.24
49
234
140
945
1.65
5.76
1.9
1.8
1179.3
1205.6
nmol/l
0.12
111
711
86
516
1.80
5.39
5.3
6.2
13.3
11.5
kpa
2.14
81
500
86
516
1.80
5.39
5.3
6.2
5.1
5.1
kpa
0.06
81
499
86
518
1.79
5.32
5.2
6.2
1.4
1.5
mmol/l
0.04
70
400
19
59
3.30
5.22
1.4
1.3
118.4
62.4
pmol/l
1.44
19
59
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
14
35
4.08
5.20
2.8
1.9
—
—
—
0
0
9
9
10.15
5.04
2.3
1.4
—
—
—
0
0
70
404
1.84
4.97
4.6
3.3
1.8
2.1
mmol/l
0.23
59
326
18
56
3.29
4.93
1.2
1.3
—
—
—
0
0
160
1156
1.55
4.85
1.7
1.5
20.3
20.9
nmol/l
0.19
146
965
28
114
2.54
4.79
1.7
1.6
—
—
—
0
0
454
4102
1.73
4.78
30.1
11.9
76.7
76.5
ml/min/173m2
0.08
423
3298
13
33
4.01
4.73
1.1
1.0
—
—
—
0
0
35
161
2.26
4.60
1.9
2.0
—
—
—
0
0
246
1971
1.46
4.42
2.3
2.0
92.7
95.0
pmol/l
0.30
148
992
193
1475
1.48
4.41
2.9
3.0
1652.4
1371.8
ng/l
0.42
169
1246
33
151
2.26
4.40
2.4
1.5
—
—
—
0
0
7
6
11.80
4.28
1.6
1.5
—
—
—
0
0
7
6
11.80
4.28
1.0
2.2
—
—
—
0
0
22
84
2.69
4.28
1.6
1.4
—
—
—
0
0
22
84
2.69
4.28
1.6
1.4
—
—
—
0
0
24
96
2.57
4.27
3.4
2.3
1.7
1.7
mg/l
0.18
24
85
319
2700
1.45
4.21
3.6
2.9
49.6
46.9
u/l
0.28
295
2476
26
109
2.46
4.21
1.3
1.1
—
—
—
0
0
18
63
2.92
4.10
1.2
1.1
—
—
—
0
0
68
413
1.74
4.08
2.1
3.2
306.0
196.9
ng/l
0.71
63
385
256
2090
1.43
4.05
3.8
3.6
0.0
0.0
estimate
0.00
70
368
9
14
6.52
4.00
1.0
1.1
—
—
—
0
0
13
38
3.48
3.92
2.5
1.7
—
—
—
0
0
8
11
7.36
3.87
1.0
1.1
—
—
—
0
0
22
89
2.54
3.85
3.3
1.2
—
—
—
0
0
50
282
1.85
3.83
5.7
3.5
1.3
2.0
mmol/l
0.60
37
210
10
25
4.06
3.71
1.5
1.3
22.5
15.1
ug/l
—
10
25
256
2113
1.41
3.70
4.0
3.6
0.0
0.0
estimate
0.50
70
357
20
80
2.56
3.58
1.2
1.7
—
—
—
0
0
252
2084
1.40
3.55
5.3
4.9
0.0
0.0
estimate
0.00
68
357
267
2233
1.39
3.51
2.9
2.5
—
—
—
0
0
33
168
2.03
3.42
1.4
1.6
—
121.8
—
0
11
387
4212
0.70
3.16
5.7
6.5
39.8
40.6
mmol/mol
0.89
350
3880
12
39
3.12
3.10
1.2
1.1
—
—
—
0
0
33
175
1.94
3.07
2.0
2.2
138.0
579.6
ug/l
1.03
33
161
10
29
3.50
3.06
1.1
1.0
—
—
—
0
0
26
128
2.08
2.96
1.4
1.6
7.1
0.1
iu/ml
—
7
26
13
47
2.81
2.83
1.2
1.1
—
—
—
0
0
413
3778
1.42
2.83
32.2
14.1
37.6
39.8
%
4.00
273
2446
13
50
2.64
2.55
1.2
1.1
—
—
—
0
0
20
95
2.15
2.52
4.1
2.1
117.3
133.5
g/l
1.92
11
71
7
17
4.16
2.36
1.0
1.1
—
—
—
0
0
217
1838
1.31
2.33
3.8
3.8
21.4
40.3
ng/l
4.77
168
1348
53
352
1.56
2.30
5.2
3.7
94.3
83.3
ng/l
0.39
48
309
13
53
2.49
2.29
2.6
3.7
—
—
—
0
0
7
18
3.93
2.26
1.3
1.3
—
—
—
0
0
7
18
3.93
2.26
1.1
1.1
—
—
—
0
0
9
30
3.03
2.15
1.7
1.1
—
—
—
0
0
9
30
3.03
2.15
1.7
1.1
—
—
—
0
0
5
10
5.04
2.07
1.8
1.3
—
—
iu/ml
—
0
0
112
876
1.35
2.07
1.3
1.3
4.1
1.7
u/ml
0.51
24
236
10
38
2.66
2.02
1.1
1.1
—
—
—
0
0
10
38
2.66
2.02
1.1
1.1
—
—
—
0
0
75
551
1.42
2.02
1.2
1.4
—
—
—
0
0
360
3293
1.29
2.00
3.9
3.8
14.8
15.0
pmol/l
0.89
331
2941
21
113
1.89
1.94
1.5
1.4
259.5
309.0
ug/g
0.61
16
66
97
750
1.36
1.93
1.3
1.3
64.4
37.2
iu/ml
0.89
36
229
10
39
2.59
1.93
1.1
1.1
—
—
—
0
0
10
39
2.59
1.93
1.1
1.1
—
—
—
0
0
10
39
2.59
1.93
1.1
1.1
—
—
—
0
0
6
17
3.56
1.84
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
18
3.36
1.75
1.3
1.2
—
—
—
0
0
5
13
3.87
1.72
2.8
5.3
—
—
—
0
0
6
19
3.18
1.66
1.2
1.2
—
—
—
0
0
6
19
3.18
1.66
6.0
1.4
203.0
206.9
u/l
—
6
19
140
1648
0.80
1.53
4.1
4.0
12.8
7.8
mg/mmol
0.35
88
1045
7
28
2.52
1.45
2.4
2.0
—
—
—
0
0
418
4380
0.79
1.44
4.1
4.8
1.4
1.5
mmol/l
3.96
372
3985
432
4507
0.78
1.41
4.7
5.5
2.6
2.7
mmol/l
1.44
385
4110
423
4420
0.79
1.36
4.2
4.9
4.4
4.6
mmol/l
1.67
378
4046
39
275
1.45
1.35
1.4
1.3
—
42.7
—
0
15
135
1151
1.23
1.27
4.4
3.9
0.0
0.0
estimate
0.50
69
354
13
70
1.88
1.25
2.1
1.7
341.5
274.6
mu/l
0.35
13
64
16
93
1.74
1.22
5.0
2.8
14.2
16.2
%
—
9
44
5
19
2.65
1.22
1.0
1.3
—
—
—
0
0
78
628
1.28
1.20
25.0
26.3
1.2
1.3
inr
0.30
12
96
10
51
1.98
1.12
1.5
1.4
—
—
—
0
0
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
14
82
1.73
1.06
1.4
1.9
—
—
—
0
0
165
1461
1.19
1.04
2.1
2.2
211.6
269.3
u/l
0.33
154
1370
87
728
1.23
0.99
1.2
1.3
6.5
14.8
u/ml
1.37
30
268
142
1605
0.84
0.98
3.3
3.1
7.3
7.5
mmol/l
0.37
119
1338
6
29
2.08
0.89
1.2
1.0
—
—
—
0
0
14
88
1.61
0.85
1.3
1.4
—
—
—
0
0
489
4783
1.28
0.80
47.5
19.0
4.3
4.5
e12/l
13.91
483
4618
411
4248
0.86
0.76
3.7
4.3
1.3
1.3
mmol/l
0.17
364
3834
7
38
1.85
0.73
1.1
1.1
—
—
—
0
0
488
4780
1.25
0.72
47.8
19.0
219.9
244.6
e9/l
11.18
482
4627
7
41
1.72
0.70
1.1
1.1
—
—
—
0
0
415
4012
1.16
0.69
4.9
4.7
2.0
2.3
mu/l
0.51
383
3601
7
43
1.64
0.67
1.6
1.1
—
85.4
—
0
5
176
1622
1.13
0.63
4.3
3.8
—
—
—
0
0
117
1051
1.15
0.62
1.6
1.8
501.7
29384327.6
pmol/l
1.26
95
844
28
218
1.30
0.61
3.3
2.3
0.5
0.2
e6/l
0.77
28
212
105
938
1.15
0.60
2.9
2.7
0.8
0.8
ug/l
0.23
71
623
14
97
1.46
0.59
1.1
1.1
—
—
—
0
0
8
53
1.52
0.58
1.1
1.1
—
—
—
0
0
30
239
1.27
0.56
1.2
1.2
150.0
110.6
iu/ml
—
9
98
16
116
1.39
0.55
1.7
1.2
—
—
—
0
0
16
116
1.39
0.55
1.7
1.2
—
—
—
0
0
10
66
1.53
0.53
1.2
1.8
—
—
—
0
0
29
234
1.25
0.50
3.6
2.7
24.7
25.3
mmol/l
0.43
29
228
22
278
0.78
0.49
1.9
1.8
—
—
—
0
0
33
272
1.23
0.48
2.1
2.2
13.8
15.1
nmol/l
0.33
28
236
43
365
1.19
0.48
2.8
2.2
48.0
64.1
ml/min/173m2
1.74
17
140
10
68
1.48
0.47
1.4
1.5
51.8
73.1
%
—
5
45
7
48
1.46
0.47
1.7
1.5
—
—
—
0
0
13
174
0.74
0.44
1.1
1.0
—
—
—
0
0
8
60
1.34
0.40
1.0
1.0
—
—
—
0
0
55
486
1.15
0.39
1.4
1.4
—
—
—
0
0
13
98
1.33
0.37
4.0
3.8
25.4
25.9
mg/l
—
8
67
15
116
1.30
0.37
1.1
1.5
—
—
—
0
0
447
4392
1.11
0.37
4.9
5.0
5.9
6.1
mmol/l
1.66
404
3962
114
1223
0.91
0.35
1.8
1.7
1.4
1.4
mmol/l
0.03
97
1003
7
52
1.35
0.31
1.0
1.0
1.7
1.5
g/l
—
7
44
17
138
1.24
0.31
1.9
1.3
—
—
—
0
0
7
55
1.28
0.30
1.4
1.1
—
—
—
0
0
20
167
1.21
0.29
1.6
1.3
—
—
—
0
0
91
972
0.92
0.26
4.3
3.9
1.0
1.0
kg/l
0.11
19
141
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
59
633
0.92
0.20
8.1
6.8
—
—
—
0
0
45
420
1.08
0.15
1.4
1.8
1.4
1.6
%
0.69
39
355
60
632
0.94
0.13
4.0
5.1
30.6
32.4
%
0.71
38
407
17
187
0.91
0.10
1.4
1.8
—
—
—
0
0
171
1677
1.03
0.09
4.6
3.9
2.3
2.0
ug/l
0.83
153
1488
7
67
1.05
0.08
1.1
1.3
0.6
0.6
nmol/l
—
7
59
12
108
1.11
0.07
2.1
1.4
—
—
—
0
0
49
474
1.04
0.06
1.9
2.4
4.2
7.0
ug/l
1.54
42
410
10
102
0.98
0.00
1.8
1.9
44.5
42.6
nmol/l
—
10
96
0
8
0.00
0.00
0.0
1.6
—
73.9
—
0
8
136
1360
1.00
0.00
4.0
3.8
20.4
23.9
%
2.12
66
645
21
210
1.00
0.00
1.3
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
8
87
0.92
0.00
1.3
1.4
—
—
—
0
0
8
83
0.96
0.00
1.6
1.9
226.4
231.3
pmol/l
—
8
75
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
26.0
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
5
53
0.94
0.00
1.4
1.2
7.0
7.8
mmol/l
—
5
37
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MARGINAL_ZONE_LYMPHOMA_EXALLC – Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).